Skip to main content
. 2018 Nov 27;2018(11):CD012345. doi: 10.1002/14651858.CD012345.pub3

Veterans Admin 1969.

Methods Veterans Administration Trial
RCT, 2 arms, parallel (n6 LA vs SFA), up to 8 years
Summary risk of bias: moderate to high
Participants Men living at the Veterans Administration Centre
 CVD risk: low
 Control: randomised 422, analysed 422
 Intervention: randomised 424, analysed 424
 Mean years in trial: control 3.7, intervention 3.7
 % male: 100
 Age: mean control 65.6, intervention 65.4
Age range: all 54‐88 years
Smokers: intervention 283, control 279 (unknown intervention 41, control 58)
Hypertension: unclear
Medications taken by ≥ 50% of those in the control group: not reported
Medications taken by 20%‐49% of those in the control group: not reported
Medications taken by some, but < 20% of the control group: digitalis, diuretics, oestrogens, corticoids, androgens, coumarins, nicotinic acid
Location: USA
Ethnicity: white 90%, black 7%, Asian 1%, Hispanic 1%, other 1%
Interventions Type: diet provided (residential institution)
Comparison: ↑ corn, soybean, safflower and cottonseed oils (n‐6) vs usual institutional diet
Control aims: provided, total fat 40% E (whole diet provided)
 Intervention aims: total fat 40% E, 2/3 of SFA replaced by unsaturated fats (from corn, soybean, safflower and cottonseed oils), dietary cholesterol reduced (whole diet provided)
Dose aim: 2/3 of baseline SFA is increase of ˜12%E PUFA
Baseline n‐6: 4% E LA, control arm 4.8% E PUFA
Compliance by biomarkers: subcutaneous 18:2 + 18:3 11.7% fat at baseline, rising to 12.8% fat in control and 34.8% fat in intervention (after "prolonged" adherence to diet). Serum TC reduced, but not statistically significantly in intervention compared to control (‐0.37 mmol/L, 95% CI ‐0.77 to 0.03).
Compliance by dietary intake: unclear,checked using coloured tickets to assess dining room attendance ‐ described as 49% in intervention and 56% in controls. Laboratory analysis of the mean of over 400 weekly collections of diet provided:
  • Energy intake, kcal/d: intervention 2496, control 2496

  • Total fat intake, % E: intervention 38.9 (SD 1.9), control 40.1 (SD 2.2)

  • SFA intake, % E: intervention 8.3, control 18.5 (decrease 10.2% E SFA)

  • PUFA intake: not reported but shown in graph as 18:2 + 18:3 ˜12% of dietary fat (4.8% E) in control and 43% in intervention (17.2% E), increase 12.4% E

  • PUFA n‐3 intake, % E: not reported

  • PUFA n‐6 intake, % E: intervention 16.1, control 4.4 (increase 11.7% E LA)

  • Trans fat intake: not reported

  • MUFA intake, % E: intervention 14.6, control 17.1 (decrease 2.5% E MUFAs)

  • CHO intake: not reported

  • Sugars intake: not reported

  • Protein intake, % E: intervention 15.6 (SD not reported), control 15.4 (SD not reported)

  • Alcohol intake: not reported


Compliance by other methods: no others reported
Inclusion basis: aim was to increase unsaturated fats, not total PUFA. Total PUFA not reported but LA dose 11.7% E (best estimate), > 10% increase from baseline of ˜5% E
PUFA dose: 11.7% E from total PUFA (best estimate from food composition data)
Duration of intervention: up to 8‐9 years
Outcomes Main trial outcomes: mortality, heart disease
Dropouts: intervention 117, control 58 withdrawals over whole trial, a few participants were involved for up to 8‐9 years
Available outcomes: mortality, CV mortality (sudden death, definite MI, definite stroke, angina, PAD events), cancer deaths, cancer diagnoses, stroke, non‐fatal MI, total MI, CHD deaths (fatal MI and sudden death due to CHD), CHD events (any MI or sudden death due to CHD), some data on TC, but no variance info
Response to contact: attempted but no author contact established (trial published in 1969)
Notes Trial dates: recruitment 1959‐1967
Trial funding: mainly US Public Health Service, Los Angeles County Heart Assoc, Arthur Dodd Fuller Assoc, but Corn Products Co (provided Corn oil and margarine), National Soybean Processors Assoc (provided soybean oil), Pitman‐Moore Co (provided margarine), Frozen Desserts Co (imitation ice cream). All trial authors worked for academic or health institutions
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "table of random numbers used"
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Institution provided diet in a masked fashion
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Physician knowledge of allocation was assessed and found not much better than random
Incomplete outcome data (attrition bias) 
 All outcomes Low risk All followed up via Veterans Admin system
Selective reporting (reporting bias) Unclear risk No protocol or trials registry entry located
Attention bias Low risk Appeared equivalent, diet provided to both arms
Compliance Low risk Subcutaneous 18:2 + 18:3 11.7% fat at baseline, rising to 12.8% fat in control and 34.8% fat in intervention (after "prolonged" adherence to diet). TC reduced, but not statistically significantly in intervention compared to control (‐0.37 mmol/L, 95% CI ‐0.77 to 0.03).
Other bias Low risk None found